Millie
your market intelligence analyst
Search Results
Edit Save
626 results
Diabetes.co.uk (UK) 01/02/2020 06:23
Saudi Arabia, the largest Arab state in Western Asia by land area, is filled with gloriously beautiful buildings such as Al-Masjid al-Nabawi, the second holiest site of Islam, and Quba Mosque, one of the oldest mosques in the world. Travelling to Saudi British pilgrims travelling to perform Umrah and Hajj are required by Saudi government […]. .
Diabetes.co.uk (UK) 10/28/2019 09:54
Our mission is to use digital media to shape the future of healthcare. Whether that’s through our education programs or interactions on the forum, we want to improve health outcomes in every aspect of diabetes care. People with diabetes are the experts in their own condition, and we seek to bring power back to where […]. .
Diabetes.co.uk (UK) 10/24/2019 20:00
The Midlands is the region with the highest prevalence of diabetes in England, according to the latest figures released by NHS Digital. In 2018/19, the Midlands recorded 7.6% of people on the NHS register as having diabetes. This figure is higher than the previous year's figures (2017/18), which was a diabetes prevalence of 7.5%. The region with the second highest prevalence is the North East and Yorkshire with 7.3% and the North West is third-placed with a prevalence of 7.2%. The lowest prevalence is found in South East with 6.2%. The diabetes figures include type 1 diabetes, type 2 diabetes and other less common forms of diabetes mellitus. At STP level, the Black Country and Birmingham represent two major hotspots for diabetes across Engl.
Diabetes.co.uk (UK) 10/24/2019 20:00
Oral semaglutide, a tablet-based GLP-1 receptor agonist drug, has performed stronger in achieving weight loss and reduction in HbA1c than empagliflozin in a new trial. The results come from the PIONEER 2 clinical trial. The trial compared two different drug treatments in people with type 2 diabetes on metformin that had HbA1c levels of 53 mmol/mol (7.0%) and above. Oral semaglutide, marketed as Rybelsus, was recently approved for public use in the US by the Food and Drug Administration (FDA). Empagliflozin, marketed as Jardiance, is an SGLT2 inhibitor drug that was approved in the US in 2014. For people in the UK, empagliflozin is available on the NHS, but the newer drug oral semaglutide is not. The PIONEER 2 trial set out to measure the pe.
Diabetes.co.uk (UK) 10/23/2019 20:00
An infant's dummy fitted with a biosensor could be used to measure glucose levels of babies, researchers have said. The sensor could be useful for helping to diagnose babies developing diabetes or to monitor glucose levels for babies that have been diagnosed with diabetes. Babies that develop diabetes before the age of 9 months may have a type of diabetes known as neonatal diabetes.
Diabetes.co.uk (UK) 10/22/2019 20:00
Breastfeeding is associated with a 30% reduction in risk of a mother developing type 2 diabetes, according to a new analysis. This statistic applied for women who breastfed for 12 months or more. The comparison group were mothers that breastfed for less than 12 months. A 13% reduction in risk of hypertension (high blood pressure) was also found to be associated with a year or more of breastfeeding. A US team of researchers reviewed a total of nine research studies. Four of them involved data taken from trials that had looked at the link between lactation and diabetes among 206,000 women. The remaining five studies involved around 225,000 women and reviewed the association between lactation and high blood pressure. The authors of the study n.
Diabetes.co.uk (UK) 10/22/2019 20:00
Dapagliflozin (Farxiga) has been approved in the US as a treatment to reduce the risk of hospitalisation for heart failure. The US Food and Drug Administration (FDA) approved this specific use of the drug for people with type 2 diabetes that have either established cardiovascular disease or a number of cardiovascular risk factors. Made by AstraZeneca, Farxiga is a sodium glucose co-transporter 2 (SGLT2) inhibitor medication.
Diabetes.co.uk (UK) 10/21/2019 20:00
An earring and inhaler form part of a continuous glucose monitoring (CGM) and insulin delivery system shortlisted for the prestigious James Dyson Award for design. Australian student Frederique Sunstrum is named a finalist in the international awards for her system which links an earring containing a small chrome glucose sensor with a 'mist' insulin delivery device, which acts like an inhaler, and a smartphone app. The project is called Continuity and has been named as one of 20 finalists for the design award.
Diabetes.co.uk (UK) 10/20/2019 20:00
A 12-year-old from Norwich says she can now comfortably play a full game of football thanks to the world's first self-adjusting insulin pump. Tilly-Rose Dade was diagnosed with type 1 diabetes aged four but has proven diabetes will not hold her back from living an active lifestyle and one day aims to become a professional footballer. Technology is a key factor in helping Tilly-Rose to manage her condition while playing the sport.
Diabetes.co.uk (UK) 10/20/2019 20:00
New, updated guidance on foot care has been published by The National Institute for Health and Care Excellence (NICE). NICE guideline, NG19, on 'Diabetic foot problems: prevention and management' has been updated to include new recommendations on the prescribing of antibiotics for diabetic foot infections. While the guidelines are developed to set standards of healthcare for clinicians, the guidelines can also be useful for people with diabetes to know what level of care they can expect. The new guidelines include a three-page summary of the guidance on antimicrobial treatment.
Diabetes.co.uk (UK) 10/17/2019 20:00
Specialists in diabetes health teams are blocking access to diabetes technologies which could significantly improve people's lives. Dr Partha Kar, NHS England's National Specialty Advisor with a specific focus on type 1 diabetes and technology, has criticised the level variation of access to technology across the country. Speaking at a Westminster Health Forum on diabetes and technology, he said: "Pumps are a legal mandate.
Diabetes.co.uk (UK) 10/16/2019 20:00
A new analysis has looked at the considerations of whether and when statins may offer benefit beyond harm. Within the UK, statins are the most commonly used drug. Over time, the number of people eligible for statin therapy has been widened through clinical guidelines. Within their analysis, the authors explain the importance of interpretation of research data about statins. They provide an example of two different people who might be prescribed statins to help explain how benefits of statins can widely vary between different individuals: "One is a 65 year old man who smokes, does not have heart disease, but who has high total cholesterol levels and raised blood pressure. The second is a 45 year old woman who does not smoke and has raised to.

Therapeutic Areas

Clinical Trials and Phases

Business Issues

Companies - Public

Companies - Venture Funded

Financial Results

Global Markets

Global Risk Factors

Government Agencies

Job Titles

Legal and Regulatory

Cell Receptors

Cells

Diagnostics and Therapeutics

Diseases

Drugs - Brand Names

Drugs - Generic

Enzymes

Genes

Health Care

Health and Wellness

Human Anatomy

Mechanisms of Action

Medical Devices

Proteins

Sources

Strategic Scenarios

Trends

Hints:

On this page, you see the results of the search you have run.  You may also view the following:

  •  Click on this drop-down menu on the right hand side of the page, to choose between the machine learning-produced Insights Reports, or the listing of concepts extracted from the results, in chart or list format. 


  •  View the number of search results returned for the search in each of your collections, and click on any of those numbers to view the entire listing of results from the chosen collection.

  •  Use the search adjustment drop-downs to change the scope, sorting, and presentation of your results.

  •  Show or hide the record’s caption (content description).

  •  Show actions that can be made with the search result record.

  •  Click on the Save button after running your search, to save it so that its results will be updated each time relevant new content is added to the designated collection. You may choose to be notified via search alerts.

Click here for more info on Search Results

Click here for more info on Machine Learning applications